Stocks and Investing
Stocks and Investing
Mon, December 19, 2016
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 06:45 PM ] - United States, WOPRAI
[ 11:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 09:45 AM ] - United States, WOPRAI
[ 07:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 04:45 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:46 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 01:45 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Ed Arce Initiated (CDTX) at Strong Buy and Held Target at $500 on, Dec 19th, 2016
Ed Arce of HC Wainwright & Co., Initiated "Cidara Therapeutics, Inc." (CDTX) at Strong Buy and Held Target at $500 on, Dec 19th, 2016.
Ed has made no other calls on CDTX in the last 4 months.
There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Ed's Rating of Hold.
This is the rating of the analyst that currently disagrees with Ed
- Stephen Brozak of "WBB Securities" Downgraded from Hold to Strong Sell on, Friday, September 23rd, 2016
Contributing Sources